CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 7,548	$ 7,441
Short-term investments	4,541	8,278
Accounts receivable (net of allowance for doubtful accounts of $163 in 2015 and $153 in 2014) (excludes accounts receivable of $30 in 2015 and $80 in 2014 classified in Other assets)	6,414	6,626
Inventories (excludes inventories of $1,534 in 2015 and $1,664 in 2014 classified in Other assets)	5,123	5,571
Deferred income taxes and other current assets	4,941	5,257
Total current assets	28,567	33,173
Investments	13,080	13,515
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,043 in 2015 and $18,004 in 2014	12,482	13,136
Goodwill	17,761	12,992
Other Intangibles, Net	23,724	20,386
Other Assets	5,618	5,133
Total Assets	101,232	98,335
Current Liabilities
Loans payable and current portion of long-term debt	2,543	2,704
Trade accounts payable	2,023	2,625
Accrued and other current liabilities	9,610	10,523
Income taxes payable	2,119	1,606
Dividends payable	1,288	1,308
Total current liabilities	17,583	18,766
Long-Term Debt	24,124	18,699
Deferred Income Taxes	5,959	4,266
Other Noncurrent Liabilities	7,887	7,813
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2015 and 2014	1,788	1,788
Other paid-in capital	40,139	40,423
Retained earnings	45,660	46,021
Accumulated other comprehensive loss	(4,573)	(4,323)
Stockholders' equity before deduction for treasury stock	83,014	83,909
Less treasury stock, at cost: 774,869,058 shares in 2015 and 738,963,326 shares in 2014	37,427	35,262
Total Merck & Co., Inc. stockholders’ equity	45,587	48,647
Noncontrolling Interests	92	144
Total equity	45,679	48,791
Liabilities and Equity	$ 101,232	$ 98,335